|
BioE Corporation
BioE is a biomedical company whose mission is to commercialize human umbilical cord blood stem cells and the associated tools and technologies needed to develop life-enhancing therapeutics and pharmaceuticals via high-quality cellular research and drug discovery.
[Detailed Profile]
USA - Minnesota - St. Paul
BrainStorm Cell Therapeutics Inc. (OTC BB : BCLI)
BrainStorm (OTC BB: BCLI) is a company that is developing stem cell technologies to provide treatments for currently incurable neurodegenerative diseases. The Company is focused on developing adult stem cells taken from the patient's own bone marrow to treat diseases such as Parkinson's Disease (PD), Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's disease), and Spinal Cord Injury.
[Detailed Profile]
USA - New York - New York
GlobalStem, Inc.
Founded in March 2006, GlobalStem boasts a highly experienced, well-trained staff of stem cell experts. We are focused on creating standardized stem cell tools and providing contract services and technical support. Our products and services are tailored for the basic, applied, and clinical research communities. Located in Rockville, Maryland, close to Washington, DC, we are in a fast-paced, stimulating environment populated by world-class research institutions and companies.
[Detailed Profile]
USA - Maryland - Rockville
AssureImmune LLC
AssureImmune - a science based cell preservation leader - provides its clients with private adult stem cell collection and preservation medical services worldwide. The company specializes in collecting, testing, and banking an individual's own healthy adult stem cells from the peripheral blood of adults and from the cord blood of healthy new born infants.
[Detailed Profile]
USA - Florida - Boca Raton
Pluristem Therapeutics, Inc. (Nasdaq : PSTI)
Pluristem Therapeutics, Inc. (NASDAQ: PSTI; DAX: PJT) is a bio-therapeutics Company dedicated to the commercialization of non-personalized (allogeneic) stem cell therapy products for the treatment of several severe degenerative, malignant and autoimmune disorders. The Company’s first planned product, PLX-I, targets a $3 billion annual market and is intended to resolve the global shortfall of matched tissue for bone marrow transplantation (BMT). Pluristem also believes its PLacental eXpanded (PLX) cells will be helpful for a variety of other indication, including as a help to patients afflicted with Peripheral Artery Disease (PAD) with critical limb ischemia (CLI).
[Detailed Profile]
Israel - Haifa
CellResearch Corporation Pte Ltd.
Founded in 2002 by a group of dynamic clinician scientists and business angels, CellResearch Corp provides high quality primary cell strains, culture media and research service support to researchers and corporations the world over. With numerous cumulative years of professional expertise between our researchers, scientists and development team you can count on our technical and sales specialists to serve your needs while you concentrate on your research program.
[Detailed Profile]
Singapore
UK Health Solutions
UK Health Solutions is an organisation focusing on working towards developing health solutions that make a different. Our Cord Blood Stem Cells Storage service is our primary service offered to consumers, allowing parents-to-be to store their child's stem cells for future family use.
[Detailed Profile]
United Kingdom - Watford
Epistem Ltd. (London Stock Exchange : EHP)
Epistem is a biotechnology company applying its expertise in epithelial stem cells in the areas of oncology and gastrointestinal diseases as well as dermatological applications. Epistem has become recognised as a specialist in epithelial tissue and stem cell analyses. Our heritage is based on our expert science and know how in the field of epithelial tissue and adult epithelial stem cell biology.
[Detailed Profile]
United Kingdom - Manchester
HemaCare Corporation (OTC BB : HEMA)
HemaCare collects, processes and distributes human blood products to hospitals and research-related organizations. We operate donor centers and mobile donor vehicles to collect transfusable blood products from donors, and offer human-derived blood products to health research organizations. HemaCare also provides blood related services, principally therapeutic apheresis procedures, stem cell collection and other blood treatments, to patients and in connection with clinical trials.
[Detailed Profile]
USA - California - Van Nuys
StemTech-International
StemTech-International Sdn Bhd, a wholly-owned subsidiary of MESDAQ - listed TMC Life Sciences Berhad, is dedicated to cord blood and adult stem cell harvesting, processing and cryo-preservation (banking).
[Detailed Profile]
Malaysia - Selangor
Reliance Life Sciences
Reliance Life Sciences is developing a wide range of novel research-led, cell-based therapies with the objective of bringing about an era of regenerative medicine. Several groups work in the areas of Embryonic Stem Cells and Stem Cell Enriched Cord Blood Repository.
[Detailed Profile]
- Navi Mumbai
ReachBio LLC
ReachBio provides specialized contract assays, contract research, and educational and consulting services to biopharmaceutical, agrichemical and other life science organizations worldwide. Our focus is on helping our clients expand their own organizations’ capabilities by efficiently harnessing our extensive knowledge and expertise in clinical and industrial stem cell and progenitor cell biology for their benefit. We operate strictly through a fee-for-service model in which the client owns all new intellectual property generated.
[Detailed Profile]
USA - Washington - Seattle
Glycosan BioSystems, Inc.
The company develops (stem) cell culture technologies.
[Detailed Profile]
USA - Utah - Salt Lake City
Cryo-Save AG (London : NL0006091969GBGBXAIM B27Z1G4CRYO)
Cryo-Save is the leading family umbilical cord blood stem cell bank in Europe by stem cell samples with over 60.000 stored. Cryo-Save is not involved in any kind of commercialisation or manipulation of stem cells for therapeutic purposes and is only storing adult stem cells
[Detailed Profile]
Belgium - Pfäffikon
BabyTooth Technologies, Inc.
Tooth stem cell preservation.
[Detailed Profile]
USA
Stem Cell Innovations ( SCI ) (OTC BB : SCLL)
Stem Cell Innovations is a publicly-traded (SCLL.OB) cell biology company. The company is well positioned to become a leader in the development of next generation drug discovery solutions including human cellular disease models and cell-based therapies. SCI's proprietary stem cell platform named PluriCells (TM) is capable of generating a broad range of differentiated human cell types.
[Detailed Profile]
USA - Texas - Houston
Stemedica Cell Technologies, Inc.
Applying stem cell technology to save, restore and improve lives.
[Detailed Profile]
USA - California - San Diego
Stem Cell Technology Company
Stem Cell Technology Company, the first Iranian private center on tissue engineering has been established since 2004. Though the main focus of the present time is on research projects, development of clinical products for the regeneration of damaged or diseased tissues is the long-term objective of this center.
[Detailed Profile]
- Iran - Tehran
Royan Institute
The Department of Stem Cells was established in 2002 to establish embryonic stem cell lines and to differentiate them to some different kinds of cells including: Cardiomyocytes, Beta Cells, and Neural Cells. Thereafter, it expanded to nine main research groups containing Embryonic/Adult Stem Cell Biology, Neural, Beta, and Germ Cell, Heart, Eye, Liver and Physicochemical Factors. All these endeavourers made us the pioneer in Stem Cell research in Iran.
[Detailed Profile]
Iran - Tehran
Stemina Biomarker Discovery, Inc.
Stemina’s innovative cell based assays arise from the strategic convergence of two groundbreaking technologies: stem cells and metabolomics. As a result, Stemina discovers and validates small molecules as biomarkers for high throughput drug screening and disease diagnostics in an all human system. Metabolomics enables the discovery of small molecules that can be used as candidate biomarkers of disease and pharmacological efficacy or toxicity.
[Detailed Profile]
|